総合診療科

Keyphrases

1. K-ras 100%
2. Japan 91%
3. KRAS mutation 73%
4. Human Pancreatic Cancer Cell Line 73%
5. Anorexia Nervosa 73%
6. Antisense Oligonucleotides 73%
7. Chronic Pancreatitis 73%
8. Syrian Hamster 73%
9. Point mutation 70%
10. Pancreatic Cancer 58%
11. Young Female 51%
12. Hamster 51%
13. Healthcare Professionals 42%
14. Psychosomatic Medicine 36%
15. Rural Island 36%
16. Medical Undergraduates 36%
17. Medical Interviewing 36%
18. Seamless Communication 36%
19. Patient's Family 36%
20. Endoscopic Stent Placement 36%
21. Pancreas Divisum 36%
22. Minor Papilla 36%
23. Training Course 36%
24. Invasiveness 36%
25. Severe Thrombocytopenia 36%
26. Nonpain Symptoms 36%
27. Spontaneous Pneumothorax 36%
28. Endoscopic Placement 36%
29. Somatic Complaints 36%
30. Life-threatening 36%
31. Rapid Recovery 36%
32. Number of Pain Sites 36%
33. Counseling 36%
34. Systems Theory 36%
35. Home Medical Care 36%
36. Young Women 36%
37. Malignant Biliary Obstruction 36%
38. Curative Resection 36%
39. Atypical Presentation 36%
40. Metallic Stent 36%
41. Growth Inhibition 36%
42. Educational Program 36%
43. Family-centered 36%
44. Weight Gain 36%
45. Phenomenology 36%
46. Pathophysiologic 36%
47. Incidental 36%
48. Dietary Change 36%
49. Metastatic Pattern 36%
50. Long-term Care 36%
51. Spouses 36%
52. Re-administration 36%
53. Metastasis 36%
54. MPO-ANCA 36%
55. Hypertrophic Pachymeningitis 36%
56. Home Visits 36%
57. Therapeutic Strategies 36%
58. Pancreatic Cancer Tissue 36%
59. Drug-induced Liver Injury 36%
60. Scutellariae Radix 36%
61. Celiac Artery Compression Syndrome 36%
62. Kampo Formula 36%
63. Abdominal Pain 30%
64. Caregivers 30%
65. Pain Complaints 29%
66. Inoculation 29%
67. Pancreas 28%
68. Necropsy 26%
69. General Practitioners 25%
70. Older Adults 24%
71. Second Surgery 24%
72. Headache 24%
73. Health Maintenance 24%
74. Median Arcuate Ligament 24%
75. Fever 24%
76. BxPC-3 21%
77. Tissue Implantation 21%
78. Organic Disease 21%
79. Invasive Activity 21%
80. Subcutaneous Tissue 21%
81. Lung 21%
82. Community Health 20%
83. Nitrosamines 19%
84. Codon 12 19%
85. Health Status 18%
86. Social Roles 18%
87. Elderly Living 18%
88. Community-based Participatory Research 18%
89. Realist Approach 18%
90. General Public 18%
91. PANC-1 18%
92. Endoscopic Stenting 18%
93. Pancreatic Stone 18%
94. Rural Japan 18%
95. Sho-saiko-to 18%
96. Liver Injury 18%
97. Public Health nurse 18%
98. Medical Staff 15%
99. Pancreatic Juice 15%
100. MIA PaCa-2 14%

Medicine and Dentistry

1. Anorexia Nervosa 73%
2. Chronic Pancreatitis 73%
3. Disease 57%
4. Pancreas Cancer 54%
5. Surgery 48%
6. Ras Signaling 45%
7. Quality of Life 36%
8. Psychosomatic Medicine 36%
9. Physician 36%
10. Pneumomediastinum 36%
11. Cholestasis 36%
12. Point Mutation 36%
13. Pancreatic Cancer Cell Line 36%
14. Oncogene Ras 36%
15. Thrombocytopenia 36%
16. Dietary Change 36%
17. Kampo 36%
18. Counseling 36%
19. Median Arcuate Ligament Syndrome 36%
20. Scutellariae Radix 36%
21. Role Playing 36%
22. Toxic Hepatitis 36%
23. Antisense Oligonucleotide 36%
24. Myeloperoxidase 36%
25. Neutrophil Cytoplasmic Antibody 36%
26. Headache 36%
27. Abdominal Pain 36%
28. Pancreas Divisum 36%
29. Stent Placement 36%
30. Neoplasm 27%
31. Doctor Patient Relation 24%
32. Cancer 24%
33. Pancreas Stone 24%
34. Endoscopic Stenting 24%
35. Symptomatic Treatment 18%
36. Platelet 18%
37. Xiao Chai Hu Tang 18%
38. Disorders of Consciousness 18%
39. Liver Injury 18%
40. Emergency Department 18%
41. Serositis 18%
42. Differential Diagnosis 18%
43. Magnetic Resonance Imaging 18%
44. Dura Mater 18%
45. Endoscopic Retrograde Cholangiopancreatography 18%
46. Celiac Artery 12%
47. Laparotomy 12%
48. Conservative Treatment 12%
49. Middle Age 12%
50. Epigastric Pain 12%
51. Pancreas Enzyme 12%
52. Shock Wave 12%
53. Pancreatic Duct 12%
54. Lithotripsy 12%
55. Koji 12%
56. Autopsy 9%
57. Clinical Feature 9%
58. Azacyclonol 9%
59. Gingiva Bleeding 9%
60. Neoadjuvant Therapy 9%
61. Pancreatectomy 9%
62. Nitrosamine 9%
63. Adenocarcinoma Cell Line 9%
64. Malignant Neoplasm 9%
65. Medical History 9%
66. Surgical Approach 9%
67. Adjuvant Therapy 9%
68. Asthma 9%
69. Pancreas Carcinoma 9%
70. Pancreas Adenocarcinoma 9%
71. Codon 9%
72. Splenectomy 9%
73. Outpatient 9%
74. Nutritional Status 9%
75. Adverse Drug Reaction 9%
76. Bone Marrow Examination 9%
77. Disseminated Intravascular Coagulation 9%
78. Antisense Therapy 9%
79. Bleeding Diathesis 9%
80. Phosphorothioic Acid 9%
81. Awareness 9%
82. Epistaxis 9%
83. Gastrointestinal Bleeding 9%
84. Hypoplasia 9%
85. In Vitro 9%
86. Purpura 9%
87. Cell Line 9%
88. Carcinogenesis 9%
89. Oligonucleotide Targeting 9%
90. Autoantibodies 9%
91. Low Platelet Count 9%
92. Diet Supplementation 9%
93. Drug Therapy 9%
94. Pancreas Function 6%
95. Disease Course 6%
96. Physical Examination 6%
97. Anamnesis 6%
98. Antidepressant 6%